Success Stories: EB-1A Approved for Postdoctoral Research Fellow in Maryland in the Field of Regenerative Medicine
On June 3rd, 2014, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Research Fellow in the Field of Regenerative Medicine (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Research Fellow
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Maryland
Approval Notice Date: June 3, 2014
Processing Time: 3 months, 10 days
In this case, the client that we had the opportunity to work with was a Postdoctoral Research Fellow from India in the field of Regenerative Medicine. He had conducted his research in the highly specialized areas of stem cells. His work had resulted in 7 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 161 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 30 manuscripts for distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “Much of his research work focuses on the differentiation of stem cells to different types of neuronal cells and the use of these to create a model of the human nervous system. His efforts have made significant progress towards the development of treatments for many nervous system disorders. His expertise extends beyond this field, however, and he has also published on other areas of Regenerative Medicine including tissue engineering and the technique of electrospinning. This represents a wide range of expertise and a clear and knowledgeable research acumen.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Regenerative Medicine, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 3 months and 10 days.